GlaxoSmithKline GmbH & Co. KG
- Pharmaceutical Sales 2009
-
Worldwide: 26.7 billion Euro
In Germany: 1.013 billion Euro
- Product Range
-
Pharmaceutical products (medicines and vaccines) directed to the following therapeutic areas:
Respiratory, Anti-bacterials, Anti-virals, Anti-malarials, Cardiovascular and Urogenital, Skin, Cancer, Anaesthesia, Pain, Metabolic, Gastrointestinal, Central Nervous System (CNS) - Key Research Areas
- Late Stage pharmaceuticals and vaccines pipeline: Biopharmaceuticals, Metabolic, Neurosciences, Oncology, Vaccines(Prophylactic and Therapeutic)
- R&D Expenditure 2009
-
Worldwide: 4.42 billion Euro
in Germany: n/a
- Employees in the Pharmaceuticals Division 2009
-
Worldwide: 99,000 (Pharma und Consumer Healthcare)
Germany: 2,080 (Pharma)
(All data based on corporate information, as of: 07/2010)
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Suggest page
Print page
Bookmark page